Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)

SHE:300016 Revenue

Beijing Beilu Pharmaceutical had revenue of 320.37M CNY in the quarter ending March 31, 2026, with 13.33% growth. This brings the company's revenue in the last twelve months to 1.24B, up 17.40% year-over-year. In the year 2025, Beijing Beilu Pharmaceutical had annual revenue of 1.21B with 22.54% growth.

• Revenue (ttm): 1.24B
• Revenue Growth: +17.40%
• P/S Ratio: 3.54
• Revenue / Employee: 1.05M
• Employees: 1,188
• Market Cap: 4.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.21B	221.72M	22.54%
Dec 31, 2024	983.55M	92.84M	10.42%
Dec 31, 2023	890.72M	124.84M	16.30%
Jan 1, 2023	765.88M	-94.02M	-10.93%
Jan 1, 2022	859.91M	32.57M	3.94%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error